Literature DB >> 9597254

Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control.

J J Schentag1, J M Hyatt, J R Carr, J A Paladino, M C Birmingham, G S Zimmer, T J Cumbo.   

Abstract

We extensively studied the epidemiology and time course of endemic methicillin-resistant Staphylococcus aureus (MRSA) in the Millard Fillmore Hospital, a 600-bed teaching hospital in Buffalo. The changeover from methicillin-susceptible S. aureus to MRSA begins on the first hospital day, when patients are given cefazolin as presurgical prophylaxis. Under selective antibiotic pressure, colonizing flora change within 24 to 48 hours. For patients remaining hospitalized, subsequent courses of third-generation cephalosporins further select and amplify the colonizing MRSA population. Therefore, managing antibiotic selective pressure might be essential. Other strategies include attention to dosing, so that serum concentrations of drug exceed the minimum inhibitory concentration, and antibiotic cycling. Although there are some promising new antibiotics on the horizon, it is necessary to deal with many resistance patterns by using the combined strategies of infection control and antibiotic management.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9597254     DOI: 10.1086/520287

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

Review 1.  Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

Authors:  Steven Y C Tong; Luke F Chen; Vance G Fowler
Journal:  Semin Immunopathol       Date:  2011-12-11       Impact factor: 9.623

2.  Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.

Authors:  Jill M Butterfield; Brian T Tsuji; Jack Brown; Elizabeth Dodds Ashley; Dwight Hardy; Kristen Brown; Alan Forrest; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

3.  Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry.

Authors:  Desiree H Fong; Albert M Berghuis
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

Review 4.  Advances in MRSA drug discovery: where are we and where do we need to be?

Authors:  Michio Kurosu; Shajila Siricilla; Katsuhiko Mitachi
Journal:  Expert Opin Drug Discov       Date:  2013-07-06       Impact factor: 6.098

Review 5.  Optimizing antibiotic therapy in the intensive care unit setting.

Authors:  M H Kollef
Journal:  Crit Care       Date:  2001-06-28       Impact factor: 9.097

6.  Appearance of methicillin-resistant Staphylococcus aureus (MRSA) sensitive to gentamicin in a hospital with a previous endemic distinct MRSA.

Authors:  N Sopena; M Garcia-Nuñez; R Prats; M L Pedro-Botet; S Elia; J Nieto; M Sabrià
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

7.  Methicillin-resistant Staphylococcus aureus: an overview for manual therapists().

Authors:  Bart N Green; Claire D Johnson; Jonathon Todd Egan; Michael Rosenthal; Erin A Griffith; Marion Willard Evans
Journal:  J Chiropr Med       Date:  2012-03

8.  Modeling methicillin-resistant Staphylococcus aureus in hospitals: transmission dynamics, antibiotic usage and its history.

Authors:  Farida Chamchod; Shigui Ruan
Journal:  Theor Biol Med Model       Date:  2012-06-27       Impact factor: 2.432

Review 9.  Systematic review of the literature and evidence-based recommendations for antibiotic prophylaxis in trauma: results from an Italian consensus of experts.

Authors:  Daniele Poole; Arturo Chieregato; Martin Langer; Bruno Viaggi; Emiliano Cingolani; Paolo Malacarne; Francesca Mengoli; Giuseppe Nardi; Ennio Nascimben; Luigi Riccioni; Ilaria Turriziani; Annalisa Volpi; Carlo Coniglio; Giovanni Gordini
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

10.  Fight evolution with evolution: plasmid-dependent phages with a wide host range prevent the spread of antibiotic resistance.

Authors:  Ville Ojala; Jarkko Laitalainen; Matti Jalasvuori
Journal:  Evol Appl       Date:  2013-06-10       Impact factor: 5.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.